Tryp Therapeutics Inc (TRYP.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2023 | 08-2022 | 08-2021 | 08-2020 | |
| Cash Flows From Operating Activities | ||||
| Accounts receivable | -23 | 15 | -22 | N/A |
| Other Working Capital | 986 | 1,108 | -365 | 175 |
| Other Operating Activity | -4,584 | -6,932 | -4,676 | -212 |
| Operating Cash Flow | $-3,622 | $-5,809 | $-5,063 | $-36 |
| Cash Flows From Investing Activities | ||||
| Purchase Sale Intangibles | -8 | -138 | -25 | -4 |
| Investing Cash Flow | $-8 | $-138 | $-25 | $-4 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 2,146 | N/A | N/A | 5 |
| Debt Repayment | N/A | 0 | -5 | N/A |
| Common Stock Issued | 0 | 4,150 | 7,003 | 1,069 |
| Other Financing Activity | 0 | -13 | 763 | -14 |
| Financing Cash Flow | $2,146 | $4,137 | $7,761 | $1,060 |
| Beginning Cash Position | 1,882 | 3,692 | 1,019 | 0 |
| End Cash Position | 398 | 1,882 | 3,692 | 1,019 |
| Net Cash Flow | $-1,484 | $-1,810 | $2,673 | $1,019 |
| Free Cash Flow | ||||
| Operating Cash Flow | -3,622 | -5,809 | -5,063 | -36 |
| Capital Expenditure | -8 | -138 | -25 | -4 |
| Free Cash Flow | -3,630 | -5,947 | -5,087 | -41 |